13F-HR filed by SILVERARC CAPITAL MANAGEMENT, LLC
SILVERARC CAPITAL MANAGEMENT, LLC filed this 13F-HR for the quarter ended 2025-12-31, filed 2026-02-12, with 68 holding rows worth $720,050,731.
- Accession
- 0001420506-26-000321
- Filer
- CIK 1816307
- Filed
- 2026-02-12
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q4 2025
A holdings report, 68 entries on the cover page, a total value of $720,050,731 stated on the cover page (in dollars after the unit check, H1), rows summing to $720,050,731 with VALUE read as dollars as filed, 13F file number 028-21010. The quarter's positions are built on this report. The resolved quarter.
Other managers
- included managerSilverArc Capital, LLC 028-20993
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| ABIVAX SA- | 00370M103 | SPONSORED ADS | 422,193 | $56,934,837 | dollars as filed | |
| COGENT BIOSCIENCES INC | 19240Q201 | COM | 1,245,254 | $44,231,422 | dollars as filed | |
| UROGEN PHARMA LTD | M96088105 | COMMON STOCK | 1,738,821 | $40,723,188 | dollars as filed | |
| KALVISTA PHARMACEUTICALS INC | 483497103 | COM | 2,427,118 | $39,197,956 | dollars as filed | |
| CELCUITY INC | 15102K100 | COM | 375,132 | $37,415,666 | dollars as filed | |
| NUVALENT INC COM | 670703107 | Stock | 311,430 | $31,326,744 | dollars as filed | |
| DIANTHUS THERAPEUTICS INC | 252828108 | COM | 750,136 | $30,913,105 | dollars as filed | |
| KODIAK SCIENCES INC | 50015M109 | COM | 1,023,122 | $28,606,491 | dollars as filed | |
| PRAXIS PRECISION MEDICINES I | 74006W207 | COM NEW | 82,465 | $24,305,734 | dollars as filed | |
| IMMUNOME INC | 45257U108 | COM | 1,126,210 | $24,190,991 | dollars as filed | |
| FRACTYL HEALTH INC | 35168W103 | COM | 9,840,041 | $21,648,090 | dollars as filed | |
| UNIQURE NV | N90064901 | CALL | 720,800 | $17,248,744 | dollars as filed | call |
| MONTE ROSA THERAPEUTICS INC | 61225M102 | COM | 1,029,066 | $16,135,755 | dollars as filed | |
| VERACYTE INC COM | 92337F107 | Stock | 357,558 | $15,053,192 | dollars as filed | |
| CG ONCOLOGY INC | 156944100 | COMMON STOCK | 361,158 | $14,995,280 | dollars as filed | |
| RHYTHM PHARMACEUTICALS INC | 76243J105 | COM | 135,950 | $14,552,088 | dollars as filed | |
| SYNDAX PHARMACEUTICALS INC | 87164F105 | COM | 642,899 | $13,507,308 | dollars as filed | |
| BIOGEN INC COM | 09062X103 | Stock | 75,412 | $13,271,758 | dollars as filed | |
| INSMED INC COM PAR $.01 | 457669307 | Stock | 71,256 | $12,401,394 | dollars as filed | |
| CENTESSA PHARMACEUTICALS PLC | 152309100 | SPONSORED ADS | 458,203 | $11,459,657 | dollars as filed | |
| VIRIDIAN THERAPEUTICS INC | 92790C104 | COM | 348,569 | $10,847,467 | dollars as filed | |
| ASCENDIS PHARMA A/S DKK 1.0 AD | 04351P101 | SPONSORED ADR | 49,228 | $10,497,379 | dollars as filed | |
| Pfizer Inc. | 717081103 | COM | 419,134 | $10,436,437 | dollars as filed | |
| BENITEC BIOPHARMA INC | 08205P209 | COMMON STOCK | 731,717 | $9,856,228 | dollars as filed | |
| AVALO THERAPEUTICS INC | 05338F306 | COMMON STOCK | 524,436 | $9,523,758 | dollars as filed | |
| GUARDANT HEALTH INC COM | 40131M109 | Stock | 91,914 | $9,388,096 | dollars as filed | |
| ORIC PHARMACEUTICALS INC | 68622P109 | COM | 1,116,604 | $9,133,821 | dollars as filed | |
| VAXCYTE INC COM | 92243G108 | Stock | 148,787 | $6,865,032 | dollars as filed | |
| TREVI THERAPEUTICS INC COM | 89532M101 | Stock | 541,240 | $6,776,325 | dollars as filed | |
| GOSSAMER BIO INC COM | 38341P102 | Stock | 2,135,722 | $6,620,738 | dollars as filed | |
| SPYRE THERAPEUTICS INC | 00773J202 | COM NEW | 187,737 | $6,150,264 | dollars as filed | |
| LEXEO THERAPEUTICS INC | 52886X107 | COMMON STOCK | 617,608 | $6,132,847 | dollars as filed | |
| AMYLYX PHARMACEUTICALS INC | 03237H101 | COM | 506,242 | $6,115,403 | dollars as filed | |
| CERUS CORP | 157085101 | COM | 2,814,383 | $5,797,629 | dollars as filed | |
| COMPASS THERAPEUTICS INC | 20454B104 | COM | 1,051,343 | $5,645,712 | dollars as filed | |
| SOLENO THERAPEUTICS INC | 834203309 | COM | 117,485 | $5,439,556 | dollars as filed | |
| COMPUGEN LTD | M25722105 | ORD | 3,479,805 | $5,324,102 | dollars as filed | |
| CELLDEX THERAPEUTICS INC NEW | 15117B202 | COM NEW | 191,074 | $5,189,570 | dollars as filed | |
| OLEMA PHARMACEUTICALS INC | 68062P106 | COM | 206,280 | $5,157,000 | dollars as filed | |
| ERASCA INC COM | 29479A108 | Stock | 1,317,584 | $4,901,412 | dollars as filed | |
| KALVISTA PHARMACEUTICALS INC | 483497903 | CALL | 290,600 | $4,693,190 | dollars as filed | call |
| FULCRUM THERAPEUTICS INC | 359616109 | COMMON STOCK | 394,650 | $4,463,492 | dollars as filed | |
| FULCRUM THERAPEUTICS INC | 359616909 | COM | 391,900 | $4,432,389 | dollars as filed | call |
| AARDVARK THERAPEUTICS INC | 002942100 | COM | 303,939 | $3,989,199 | dollars as filed | |
| C4 THERAPEUTICS INC | 12529R107 | COM STK | 1,994,224 | $3,808,968 | dollars as filed | |
| SURROZEN INC | 86889P208 | COMMON STOCK | 157,323 | $3,555,500 | dollars as filed | |
| CONTINEUM THERAPEUTICS INC CL A | 21217B100 | Stock | 307,540 | $3,515,182 | dollars as filed | |
| MINERALYS THERAPEUTICS INC | 603170101 | COM | 94,983 | $3,446,933 | dollars as filed | |
| RELAY THERAPEUTICS INC COM | 75943R102 | Stock | 398,167 | $3,368,493 | dollars as filed | |
| ABEONA THERAPEUTICS INC | 00289Y206 | COM NEW | 627,738 | $3,308,179 | dollars as filed | |
| TELA BIO INC | 872381108 | COM | 2,647,512 | $3,124,064 | dollars as filed | |
| UNIQURE NV | N90064101 | SHS | 126,047 | $3,016,305 | dollars as filed | |
| TARSUS PHARMACEUTICALS INC | 87650L103 | COMMON STOCK | 36,124 | $2,957,833 | dollars as filed | |
| KYMERA THERAPEUTICS INC | 501575104 | COM | 34,589 | $2,691,370 | dollars as filed | |
| ULTRAGENYX PHARMACEUTICAL IN | 90400D908 | CALL | 110,000 | $2,530,000 | dollars as filed | call |
| NEXTCURE INC | 65343E207 | COM NEW | 176,057 | $2,498,249 | dollars as filed | |
| ELUTIA INC | 05479K106 | CL A COM | 2,751,314 | $1,905,835 | dollars as filed | |
| SIONNA THERAPEUTICS INC | 829401108 | COMMON STOCK | 41,460 | $1,705,664 | dollars as filed | |
| CYTOMX THERAPEUTICS INC | 23284F105 | COMMON STOCK | 385,974 | $1,644,249 | dollars as filed | |
| X4 PHARMACEUTICALS INC | 98420X202 | COMMON STOCK | 357,387 | $1,429,548 | dollars as filed | |
| EDGEWISE THERAPEUTICS INC | 28036F105 | COM | 42,052 | $1,043,520 | dollars as filed | |
| RADIOPHARM THERANOSTICS LTD | 75041J101 | SPONSORED ADS | 187,406 | $978,259 | dollars as filed | |
| 4D MOLECULAR THERAPEUTICS INC COM | 35104E100 | Stock | 100,000 | $750,000 | dollars as filed | |
| Adagio Med Hldgs Inc Com | 00534B100 | Common Stock | 515,384 | $535,999 | dollars as filed | |
| RAPPORT THERAPEUTICS INC COM | 75383L102 | Stock | 9,659 | $293,054 | dollars as filed | |
| PALISADE BIO INC | 696389402 | COMMON STOCK | 102,108 | $239,954 | dollars as filed | |
| IBIO INC | 451033708 | CMN | 106,000 | $204,580 | dollars as filed | |
| Rocket Pharmaceuticals Inc W Exp 09/02/202 | 77313F114 | Warrant | 104,828 | $2,547 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001420506-26-000321 | this filing | 2026-02-12 | acceptance time not in the bulk data set |